November 26th, 2014
•We describe a protocol for deriving lentiviral-based reprogrammed and characterized factor-free human induced pluripotent stem cells and conversion into putative clinical-grade conditions.
Related Videos
Derivation of Human Embryonic Stem Cells by Immunosurgery
Isolation and Derivation of Mouse Embryonic Germinal Cells
Differentiation of Embryonic Stem Cells into Oligodendrocyte Precursors
Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells
Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
Selecting and Isolating Colonies of Human Induced Pluripotent Stem Cells Reprogrammed from Adult Fibroblasts
Reprogramming Human Somatic Cells into Induced Pluripotent Stem Cells (iPSCs) Using Retroviral Vector with GFP
Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
Efficient Generation Human Induced Pluripotent Stem Cells from Human Somatic Cells with Sendai-virus
High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved